Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Apr 04, 2027 1:00 PM - Apr 04, 2027 4:30 PM

Global Convergence in Risk Management Guidance Driving New Innovation Opportunities

This is a pre-meeting Short Course in conjunction with the Global Pharmacovigilance and Risk Management Strategies Conference

Instructors

Mark  Perrott, PhD

Mark Perrott, PhD

Managing Partner, Axian Consulting Ltd., United Kingdom

Mark is a founder and managing partner at Axian Consulting, where he focuses on improving benefit-risk balance and outcomes for patients through improving communication and adding value using digital approaches. He has a >20 year pharma career which has included industry (Wellcome, GW, GSK and AZ) and consultancy roles (WCI, Foresight, PopeWoodhead, Huron and now is a founder and managing partner of Axian Consulting). He is now focusing on the opportunities presented by improved benefit-risk management approaches to enhance risk management decision-making in development and on adding value to the interactions of industry and customers to maximise B-R balance and improve outcomes in REMS and aRMM programmes.

Stephanie  Millican, PhD, MSc

Stephanie Millican, PhD, MSc

Deputy Director Benefit Risk Evaluation, Safety and Surveillance, MHRA, United Kingdom

Stephanie is the Deputy Director of Benefit Risk Evaluation II in the Safety and Surveillance group at the MHRA. Prior to her current role she held a variety of management and assessor positions in the Agency. She has a masters degree in Clinical Pharmacology and a PhD in Cell Biology. She joined the Agency following a career in academia and has now over 20 years experience in drug regulation with particular experience in post-authorisation procedures and pharmacovigilance.

Representative Invited

Representative Invited

Perspective Pharmacovigilance, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.